<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB04191</drugbank-id>
  <drugbank-id>EXPT01606</drugbank-id>
  <name>Skf 107457</name>
  <description/>
  <cas-number>144285-77-8</cas-number>
  <unii/>
  <average-mass>577.7128</average-mass>
  <monoisotopic-mass>577.347548883</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.</description>
    <direct-parent>Hybrid peptides</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Peptidomimetics</class>
    <subclass>Hybrid peptides</subclass>
    <alternative-parent>Alanine and derivatives</alternative-parent>
    <alternative-parent>Alpha amino acid amides</alternative-parent>
    <alternative-parent>Alpha amino acid esters</alternative-parent>
    <alternative-parent>Amphetamines and derivatives</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Dipeptides</alternative-parent>
    <alternative-parent>Fatty acid esters</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Methyl esters</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>N-acyl amines</alternative-parent>
    <alternative-parent>N-acyl-alpha amino acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Secondary carboxylic acid amides</alternative-parent>
    <alternative-parent>Valine and derivatives</alternative-parent>
    <substituent>Alanine or derivatives</substituent>
    <substituent>Alcohol</substituent>
    <substituent>Alpha-amino acid amide</substituent>
    <substituent>Alpha-amino acid ester</substituent>
    <substituent>Alpha-amino acid or derivatives</substituent>
    <substituent>Alpha-dipeptide</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid or derivatives</substituent>
    <substituent>Amphetamine or derivatives</substituent>
    <substituent>Aromatic homomonocyclic compound</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxamide group</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Carboxylic acid ester</substituent>
    <substituent>Fatty acid ester</substituent>
    <substituent>Fatty acyl</substituent>
    <substituent>Fatty amide</substituent>
    <substituent>Hybrid peptide</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Methyl ester</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Monocyclic benzene moiety</substituent>
    <substituent>N-acyl-alpha amino acid or derivatives</substituent>
    <substituent>N-acyl-amine</substituent>
    <substituent>N-substituted-alpha-amino acid</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Secondary carboxylic acid amide</substituent>
    <substituent>Valine or derivatives</substituent>
  </classification>
  <salts/>
  <synonyms/>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Peptides</category>
      <mesh-id>D010455</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1aaq</pdb-entry>
    <pdb-entry>1heg</pdb-entry>
    <pdb-entry>1siv</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>1.22</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-4.4</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.37e-02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>0.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>methyl (2S)-2-[(2S)-2-[(4S,5S)-5-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-4-hydroxy-6-phenylhexanamido]-3-methylbutanamido]-3-methylbutanoate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>methyl (2S)-2-[(2S)-2-[(4S,5S)-5-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-4-hydroxy-6-phenylhexanamido]-3-methylbutanamido]-3-methylbutanoate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>577.7128</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>577.347548883</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[H][C@@](C)(N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CC=CC=C1)[C@@]([H])(O)CCC(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)OC</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C29H47N5O7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C29H47N5O7/c1-16(2)24(28(39)34-25(17(3)4)29(40)41-7)33-23(36)14-13-22(35)21(15-20-11-9-8-10-12-20)32-27(38)19(6)31-26(37)18(5)30/h8-12,16-19,21-22,24-25,35H,13-15,30H2,1-7H3,(H,31,37)(H,32,38)(H,33,36)(H,34,39)/t18-,19-,21-,22-,24-,25-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>IUDCAKKZLXFOQA-QJAPXLAMSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>188.95</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>152.41</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>62.56</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>17</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>12.05</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>8.09</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>444196</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508521</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>392186</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>903</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>PSI</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL49004</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0001781</id>
      <name>Gag-Pol polyprotein</name>
      <organism>SIV-mac</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P05896" source="Swiss-Prot">
        <name>Gag-Pol polyprotein</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Gag-Pol polyprotein and Gag polyprotein may regulate their own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, Gag-Pol and Gag would promote translation, whereas at high concentration, the polyproteins encapsidate genomic RNA and then shutt off translation (By similarity).Matrix protein p17 has two main functions: in infected cell, it targets Gag and Gag-pol polyproteins to the plasma membrane via a multipartite membrane-binding signal, that includes its myristointegration complex. The myristoylation signal and the NLS exert conflicting influences its subcellular localization. The key regulation of these motifs might be phosphorylation of a portion of MA molecules on the C-terminal tyrosine at the time of virus maturation, by virion-associated cellular tyrosine kinase. Implicated in the release from host cell mediated by Vpu (By similarity).Capsid protein p24 forms the conical core that encapsulates the genomic RNA-nucleocapsid complex in the virion. The core is constituted by capsid protein hexamer subunits. The core is disassembled soon after virion entry. Interaction with host PPIA/CYPA protects the virus from restriction by host TRIM5-alpha and from an unknown antiviral activity in host cells. This capsid restriction by TRIM5 is one of the factors which restricts SIV to the simian species (By similarity).Nucleocapsid protein p7 encapsulates and protects viral dimeric unspliced (genomic) RNA. Binds these RNAs through its zinc fingers. Facilitates rearangement of nucleic acid secondary structure during retrotranscription of genomic RNA. This capability is referred to as nucleic acid chaperone activity (By similarity).The aspartyl protease mediates proteolytic cleavages of Gag and Gag-Pol polyproteins during or shortly after the release of the virion from the plasma membrane. Cleavages take place as an ordered, step-wise cascade to yield mature proteins. This process is called maturation. Displays maximal activity during the budding process just prior to particle release from the cell. Also cleaves Nef and Vif, probably concomitantly with viral structural proteins on maturation of virus particles. Hydrolyzes host EIF4GI and PABP1 in order to shut off the capped cellular mRNA translation. The resulting inhibition of cellular protein synthesis serves to ensure maximal viral gene expression and to evade host immune response (By similarity).Reverse transcriptase/ribonuclease H (RT) is a multifunctional enzyme that converts the viral dimeric RNA genome into dsDNA in the cytoplasm, shortly after virus entry into the cell. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3' to 5' endonucleasic mode. Conversion of viral genomic RNA into dsDNA requires many steps. A tRNA binds to the primer-binding site (PBS) situated at the 5'-end of the viral RNA. RT uses the 3' end of the tRNA primer to perform a short round of RNA-dependent minus-strand DNA synthesis. The reading proceeds through the U5 region and ends after the repeated (R) region which is present at both ends of viral RNA. The portion of the RNA-DNA heteroduplex is digested by the RNase H, resulting in a ssDNA product attached to the tRNA primer. This ssDNA/tRNA hybridizes with the identical R region situated at the 3' end of viral RNA. This template exchange, known as minus-strand DNA strong stop transfer, can be either intra- or intermolecular. RT uses the 3' end of this newly synthesized short ssDNA to perform the RNA-dependent minus-strand DNA synthesis of the whole template. RNase H digests the RNA template except for two polypurine tracts (PPTs) situated at the 5'-end and near the center of the genome. It is not clear if both polymerase and RNase H activities are simultaneous. RNase H can probably proceed both in a polymerase-dependent (RNA cut into small fragments by the same RT performing DNA synthesis) and a polymerase-independent mode (cleavage of remaining RNA fragments by free RTs). Secondly, RT performs DNA-directed plus-strand DNA synthesis using the PPTs that have not been removed by RNase H as primers. PPTs and tRNA primers are then removed by RNase H. The 3' and 5' ssDNA PBS regions hybridize to form a circular dsDNA intermediate. Strand displacement synthesis by RT to the PBS and PPT ends produces a blunt ended, linear dsDNA copy of the viral genome that includes long terminal repeats (LTRs) at both ends (By similarity).Integrase catalyzes viral DNA integration into the host chromosome, by performing a series of DNA cutting and joining reactions. This enzyme activity takes place after virion entry into a cell and reverse transcription of the RNA genome in dsDNA. The first step in the integration process is 3' processing. This step requires a complex comprising the viral genome, matrix protein, Vpr and integrase. This complex is called the pre-integration complex (PIC). The integrase protein removes 2 nucleotides from each 3' end of the viral DNA, leaving recessed CA OH's at the 3' ends. In the second step, the PIC enters cell nucleus. This process is mediated through integrase and Vpr proteins, and allows the virus to infect a non dividing cell. This ability to enter the nucleus is specific of lentiviruses, other retroviruses cannot and rely on cell division to access cell chromosomes. In the third step, termed strand transfer, the integrase protein joins the previously processed 3' ends to the 5' ends of strands of target cellular DNA at the site of integration. The 5'-ends are produced by integrase-catalyzed staggered cuts, 5 bp apart. A Y-shaped, gapped, recombination intermediate results, with the 5'-ends of the viral DNA strands and the 3' ends of target DNA strands remaining unjoined, flanking a gap of 5 bp. The last step is viral DNA integration into host chromosome. This involves host DNA repair synthesis in which the 5 bp gaps between the unjoined strands are filled in and then ligated. Since this process occurs at both cuts flanking the SIV genome, a 5 bp duplication of host DNA is produced at the ends of SIV integration. Alternatively, Integrase may catalyze the excision of viral DNA just after strand transfer, this is termed disintegration (By similarity).</specific-function>
        <gene-name>gag-pol</gene-name>
        <locus/>
        <cellular-location>Virion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.02</theoretical-pi>
        <molecular-weight>163370.835</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="11733">SIV-mac</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>Y00277</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>61731</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P05896</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>POL_SIVM1</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Pr160Gag-Pol</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037147|Gag-Pol polyprotein
MGARNSVLSGKKADELEKIRLRPGGKKKYMLKHVVWAANELDRFGLAESLLENKEGCQKI
LSVLAPLVPTGSENLKSLYNTVCVIWCIHAEEKVKHTEEAKQIVQRHLVMETGTAETMPK
TSRPTAPFSGRGGNYPVQQIGGNYTHLPLSPRTLNAWVKLIEEKKFGAEVVSGFQALSEG
CLPYDINQMLNCVGDHQAAMQIIRDIINEEAADWDLQHPQQAPQQGQLREPSGSDIAGTT
STVEEQIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTNILDVKQGPKEPFQSYVDR
FYKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGTNPTLEEMLTACQGVGGPGQK
ARLMAEALKEALAPAPIPFAAAQQKGPRKPIKCWNCGKEGHSARQCRAPRRQGCWKCGKM
DHVMAKCPNRQAGFFRPWPLGKEAPQFPHGSSASGADANCSPRRTSCGSAKELHALGQAA
ERKQREALQGGDRGFAAPQFSLWRRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYT
PKIVGGIGGFINTKEYKNVEIEVLGKRIKGTIMTGDTPINIFGRNLLTALGMSLNLPIAK
VEPVKSPLKPGKDGPKLKQWPLSKEKIVALREICEKMEKDGQLEEAPPTNPYNTPTFAIK
KKDKNKWRMLIDFRELNRVTQDFTEVQLGIPHPAGLAKRKRITVLDIGDAYFSIPLDEEF
RQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQYTMRHVLEPFRKANPDVTLVQYM
DDILIASDRTDLEHDRVVLQLKELLNSIGFSSPEEKFQKDPPFQWMGYELWPTKWKLQKI
ELPQRETWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTLTEEVQWTEMAEAEYE
ENKIILSQEQEGCYYQESKPLEATVIKSQDNQWSYKIHQEDKILKVGKFAKIKNTHTNGV
RLLAHVIQKIGKEAIVIWGQVPKFHLPVEKDVWEQWWTDYWQVTWIPEWDFISTPPLVRL
VFNLVKDPIEGEETYYVDGSCSKQSKEGKAGYITDRGKDKVKVLEQTTNQQAELEAFLMA
LTDSGPKANIIVDSQYVMGIITGCPTESESRLVNQIIEEMIKKTEIYVAWVPAHKGIGGN
QEIDHLVSQGIRQVLFLEKIEPAQEEHSKYHSNIKELVFKFGLPRLVAKQIVDTCDKCHQ
KGEAIHGQVNSDLGTWQMDCTHLEGKIVIVAVHVASGFIEAEVIPQETGRQTALFLLKLA
SRWPITHLHTDNGANFASQEVKMVAWWAGIEHTFGVPYNPQSQGVVEAMNHHLKNQIDRI
REQANSVETIVLMAVHCMNFKRRGGIGDMTPAERLINMITTEQEIQFQQSKNSKFKNFRV
YYREGRDQLWKGPGELLWKGEGAVILKVGTDIKVVPRRKAKIIKDYGGGKEMDSSSHMED
TGEAREVA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0003530|3171 bp
GTGTTGGAATTGTGGGAAGGAAGGACACTCTGCAAGGCAATGCAGAGCCCCAAGAAGACA
GGGATGCTGGAAATGTGGAAAAATGGACCATGTTATGGCCAAATGCCCAAACAGACAGGC
GGGTTTTTTAGGCCTTGGCCCTTGGGGAAAGAAGCCCCGCAATTTCCCCATGGCTCAAGT
GCATCAGGGGCTGACGCCAACTGCTCCCCCAGAAGAACCAGCTGTGGATCTGCTAAAGAA
CTACATGCACTTGGGCAAGCAGCAGAGAGAAAGCAGAGGGAAGCCTTACAAGGAGGTGAC
AGAGGATTTGCTGCACCTCAATTCTCTCTTTGGAGGAGACCAGTAGTCACTGCTCATATT
GAAGGACAGCCTGTAGAAGTATTATTAGATACAGGGGCTGATGATTCTATTGTAACAGGA
ATAGAGTTAGGTCCACATTATACCCCAAAAATAGTAGGAGGAATAGGAGGTTTTATTAAT
ACTAAAGAATACAAAAATGTAGAAATAGAAGTTTTAGGCAAAAGGATTAAAGGGACAATC
ATGACAGGGGACACCCCGATTAACATTTTTGGTAGAAATTTACTAACAGCTCTGGGGATG
TCTCTAAATCTTCCCATAGCTAAGGTAGAGCCTGTAAAGTCGCCCTTAAAGCCAGGAAAG
GATGGACCAAAATTGAAGCAGTGGCCATTATCAAAAGAAAAGATAGTTGCATTAAGAGAA
ATCTGTGAAAAGATGGAAAAAGATGGTCAGTTGGAGGAAGCTCCCCCGACCAATCCATAT
AACACCCCCACATTTGCTATAAAGAAAAAGGATAAAAACAAATGGAGAATGCTGATAGAT
TTTAGGGAACTAAATAGGGTCACTCAAGACTTTACGGAAGTCCAATTAGGAATACCACAC
CCTGCAGGACTAGCAAAAAGGAAAAGGATTACAGTACTGGATATAGGTGACGCATATTTC
TCTATACCTCTAGATGAAGAATTTAGGCAGTACACTGCCTTTACTTTACCATCAGTAAAT
AATGCAGAGCCAGGAAAACGATACATTTATAAGGTTCTGCCTCAGGGATGGAAGGGGTCA
CCAGCCATCTTCCAATACACTATGAGACATGTGCTAGAACCCTTCAGGAAGGCAAATCCA
GATGTGACCTTAGTCCAGTATATGGATGACATCTTAATAGCTAGTGACAGGACAGACCTG
GAACATGACAGGGTAGTTTTACAGTTAAAAGAACTCTTAAATAGCATAGGGTTTTCATCC
CCAGAAGAGAAATTCCAAAAAGATCCCCCATTTCAATGGATGGGGTACGAATTGTGGCCG
ACAAAATGGAAGTTGCAAAAGATAGAGTTGCCACAAAGAGAGACCTGGACAGTGAATGAT
ATACAGAAGTTAGTAGGAGTATTAAATTGGGCAGCTCAAATTTATCCAGGTATAAAAACC
AAACATCTCTGTAGGTTAATTAGAGGAAAAATGACTCTAACAGAGGAAGTTCAGTGGACT
GAGATGGCAGAAGCAGAATATGAGGAAAATAAAATAATTCTCAGTCAGGAACAAGAAGGA
TGTTATTACCAAGAAAGCAAGCCATTAGAAGCCACGGTGATAAAGAGTCAGGACAATCAG
TGGTCTTATAAAATTCACCAAGAAGACAAAATACTGAAAGTAGGAAAATTTGCAAAGATA
AAGAATACACATACCAATGGAGTTAGACTATTAGCACATGTAATACAGAAAATAGGAAAG
GAAGCAATAGTGATCTGGGGACAGGTCCCAAAATTCCACTTACCAGTTGAGAAGGATGTA
TGGGAACAGTGGTGGACAGACTATTGGCAGGTAACCTGGATACCGGAATGGGATTTCATC
TCAACACCACCATTAGTAAGATTAGTCTTCAATCTAGTGAAGGACCCTATAGAGGGAGAA
GAAACCTATTATGTAGATGGATCATGTAGTAAACAGTCAAAAGAAGGAAAAGCAGGATAT
ATCACAGACAGGGGCAAAGACAAGGTAAAAGTGTTAGAACAGACTACTAATCAACAAGCA
GAATTGGAAGCATTTCTCATGGCATTGACAGACTCAGGGCCAAAGGCAAATATTATAGTA
GACTCACAATATGTTATGGGAATAATAACAGGATGCCCTACAGAATCAGAGAGCAGGCTA
GTTAACCAAATAATAGAAGAAATGATCAAAAAGACAGAAATTTATGTGGCATGGGTACCA
GCACACAAAGGTATAGGAGGAAACCAAGAAATAGACCACCTAGTTAGTCAAGGGATTAGA
CAAGTTCTCTTCTTGGAAAAGATAGAGCCAGCACAAGAAGAACATAGTAAATACCATAGT
AACATAAAAGAATTGGTATTCAAATTTGGATTACCCAGACTAGTGGCCAAACAGATAGTA
GACACATGTGATAAATGTCATCAAAAAGGAGAAGCTATACATGGGCAGGTAAATTCAGAC
CTAGGGACTTGGCAAATGGATTGTACCCATCTAGAGGGAAAAATAGTCATAGTTGCAGTA
CATGTAGCTAGTGGATTCATAGAAGCAGAAGTAATTCCACAAGAAACAGGAAGACAGACA
GCACTATTTCTGTTAAAATTGGCAAGCAGATGGCCTATTACACATCTGCACACAGATAAT
GGTGCTAACTTTGCTTCGCAAGAAGTAAAGATGGTTGCATGGTGGGCAGGGATAGAGCAC
ACCTTTGGGGTACCATACAATCCACAGAGTCAGGGAGTAGTGGAAGCAATGAATCACCAC
CTGAAAAATCAAATAGATAGAATCAGGGAACAAGCAAATTCAGTAGAAACCATAGTATTA
ATGGCAGTTCATTGCATGAATTTTAAAAGAAGGGGAGGAATAGGGGATATGACTCCAGCA
GAAAGATTAATTAACATGATCACTACAGAACAAGAAATACAATTTCAACAATCAAAAAAC
TCAAAATTTAAAAATTTTCGGGTCTATTACAGAGAAGGCAGAGATCAGCTGTGGAAGGGA
CCCGGTGAGCTATTGTGGAAAGGGGAAGGAGCAGTCATCTTAAAGGTAGGAACAGACATT
AAGGTAGTACCCAGGAGAAAGGCTAAAATTATCAAAGATTATGGAGGAGGAAAAGAGATG
GATAGTAGTTCCCACATGGAGGATACCGGAGAGGCTAGAGAGGTGGCATAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00078</identifier>
            <name>RVT_1</name>
          </pfam>
          <pfam>
            <identifier>PF00540</identifier>
            <name>Gag_p17</name>
          </pfam>
          <pfam>
            <identifier>PF00607</identifier>
            <name>Gag_p24</name>
          </pfam>
          <pfam>
            <identifier>PF00552</identifier>
            <name>IN_DBD_C</name>
          </pfam>
          <pfam>
            <identifier>PF02022</identifier>
            <name>Integrase_Zn</name>
          </pfam>
          <pfam>
            <identifier>PF00075</identifier>
            <name>RNase_H</name>
          </pfam>
          <pfam>
            <identifier>PF00665</identifier>
            <name>rve</name>
          </pfam>
          <pfam>
            <identifier>PF00077</identifier>
            <name>RVP</name>
          </pfam>
          <pfam>
            <identifier>PF06815</identifier>
            <name>RVT_connect</name>
          </pfam>
          <pfam>
            <identifier>PF06817</identifier>
            <name>RVT_thumb</name>
          </pfam>
          <pfam>
            <identifier>PF00098</identifier>
            <name>zf-CCHC</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>host cell cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>viral nucleocapsid</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>aspartic-type endopeptidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA-directed DNA polymerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>exoribonuclease H activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA-directed DNA polymerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA-DNA hybrid ribonuclease activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>structural molecule activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>DNA integration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>DNA recombination</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>establishment of integrated proviral latency</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>suppression by virus of host gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral entry into host cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral penetration into host nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral release from host cell</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>